Abstract
This review was written to highlight the lessons learned in HCL in the past 25 years. It should serve as a guideline to practicing hematologists and oncologists regarding the diagnosis and management of HCL patients. It should stimulate investigators in training to realize that a disease can be understood with time; however, additional clinical observations and laboratory experiments may help to improve the survival rate even more.
Publisher
American Society of Clinical Oncology (ASCO)
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献